: Who’s afraid of Ozempic? From restaurants to package makers, companies work to calm investors’ GLP-1 jitters.
With Eli Lilly’s Zepbound set to enter the fray, companies are flooded with weight-loss drug questions
With Eli Lilly’s Zepbound set to enter the fray, companies are flooded with weight-loss drug questions